Association of Apolipoproteins E4 and C1 With Onset Age and Memory: A Study of Sporadic Alzheimer Disease in Taiwan

Abstract

Objective: To identify clinical manifestations and neuropsychological effects of Alzheimer disease (AD) in apolipoprotein (ApoE) e4 carriers and to investigate the relationships between ApoE HhaI polymorphism and apolipoprotein C1 (APOC1) HpaI polymorphism in Taiwanese patients with AD. Participants and methods: A total of 127 patients with AD and 191 elderly individuals were screened for ApoE and APOC1 polymorphism. All patients underwent neuropsychological testing, including a Mini-Mental Status Examination (MMSE), Clinical Dementia Rating (CDR), and/or the Visual Association Memory Test (VAMT) with Cognitive Abilities Screening Instrument. Results: The frequencies of the e4 and A alleles were significantly higher in the AD group. In the patients with AD, the e4 and A allele effects on those with an age-of-onset of 60 to 79 years were stronger than those with an age-of-onset of 80 years or higher. Visual Association Memory Test performance was significantly worse in e4-allele carriers but not in A-allele carriers, in the early AD, particularly in those affected with AD for less than 2 years. Although there was no statistically significant difference in genotypic frequency between patients and controls, the 2 genes were linked. In addition, the presence of the AA genotype concomitant with the e4 allele may be better associated with AD diagnosis than either factor alone. Conclusion: We conclude that the e4 allele affects neuropsychological performance and illness morbidity. Concomitantly, ApoE e4 and APOC1 A alleles have a better association with AD than ApoE e4 alone. In addition, APOC1 may partially contribute to the pathogenesis of AD, but the nature of its relationship with e4 requires further investigation.

Keywords

APOC1 ApoE Alzheimer disease neuropsychological test Visual Association Memory Test

Get full access to this article

View all access options for this article.

References

Lauer SJ , Walker D. , Elshourbagy NA , Reardon CA , Levy-Wilson B. , Taylor JM Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene. J Biol Chem. 1988;263(15):7277-7286.

Bartres-Faz D. , Clemente IC , Junque C. , et al. APOE and APOC1 genetic polymorphisms in age-associated memory impairment. Neurogenetics. 2001;3(4):215-219.

Shi J. , Zhang S. , Ma C. , et al. Association between apolipoprotein CI HpaI polymorphism and sporadic Alzheimer’s disease in Chinese. Acta Neurol Scand. 2004;109(2):140-145.

Campion D. , Dumanchin C. , Hannequin D. , et al. Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet . 1999;65(3):664-670.

Liu HC , Chou P. , Lin KN , et al. Assessing cognitive abilities and dementia in a predominantly illiterate population of older individuals in Kinmen. Psychol Med. 1994;24(3):763-770.

Lindeboom J. , Schmand B. , Turner L. , Walstra G. , Jonker C. Visual association test to detect early dementia of the Alzheimer’s type. J Neurol Neurosurg Psychiatry . 2002;73(2):126-133.

Chuang WL , Wang HM , Hsieh YC , Chang TF , Kuo HC , Huang CC Visual association memory test in differentiating early stage of Alzheimer’s disease from vascular dementia. Acta Neurol Taiwan. 2006;15(2):98-104.

Wang HK , Fung HC , Hsu WC , et al. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer’s disease and vascular dementia. J Neural Transm. 2006;113(10):1499-1509.

Nillesen WM , Smeets HJ , van Oost BA Human ApoCI HpaI restriction site polymorphism revealed by the polymerase chain reaction. Nucleic Acids Res . 1990;18(11):3428.

10.

Saunders A. , Strittmatter W. , Schmechel D. , et al. Association of apolipoprotein E alleleε4 with late-onset familial and sporadic Alzheimer’s disease. Neurology . 1993;43(8):1467-1472.

11.

Maestre G. , Ottman R. , Stern Y. , et al. Apolipoprotein E and Alzheimer’s disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37(2):254-259.

12.

Hong CJ , Liu TY , Liu HC , et al. ε4 allele of apolipoprotein E increases risk of Alzheimer’s disease in Chinese population. Neurology. 1996;46(6):1749-1751.

13.

Kawamata J. , Tanaka S. , Shimohama S. , et al. Apolipoprotein E polymorphism in Japanese patients with Alzheimer’s disease or vascular dementia. J Neurol Neurosurg Psychiatry. 1994;57(11):1414-1416.

14.

Xu P. , Berglund L. , Ramakrishnan R. , et al. A common HpaI RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res. 1999;40(1):50-58.

15.

Ki CS , Na DL , Kim DK , et al. Genetic association of an apolipoprotein C-I (APOCI) gene polymorphism with late-onset Alzheimer’s disease. Neurosci Lett. 2002;319(2):75-78.

16.

Retz W. , Thome J. , Durancy N. , et al. Potential genetic markers of sporadic Alzheimer’s dementia . Psychiatr Genet. 2001;11(13): 115-122.

17.

Xu PT , Li YJ , Qin XJ , et al. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol Dis. 2006;21(2):156-175.

18.

Xu PT , Li YJ , Qin XJ , et al. A SAGE study of apolipoprotein E3/ 3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 2007;36(3):313-331.

19.

Trivedi MA , Schmitz TW , Ries ML , et al. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer’s disease: a cross-sectional study. BMC Med. 2006;4:1.

20.

Rebeck GW , Perls TT , West HL , et al. Reduced apolipoprotein e4 allele frequency in the oldest old Alzheimer’s patients and cognitively normal individuals. Neurology. 1994;44(8):1513-1516.

21.

Lucotte G. , Turpin JC , Landais P. Apolipoprotein E-e4 allele dose in late-onset Alzheimer disease . Ann Neurol. 1994;36(4):681-682.

22.

Murman DL , Foster NL , Kilgore SP , McDonagh CA , Fink JK Apolipoprotein E and Alzheimer’s disease: strength of association is related to age of onset. Dementia. 1996 ;7(5):251-255.

23.

Bunce D. , Fratiglioni L. , Small BJ , Winblad B. , Bäckman L. APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging. Neurology. 2004;63(5):816-821.

24.

Boss JL , Paller KA Brain substrates of implicit and explicit memory: the importance of concurrently acquired neural signals of both memory types. Neuropsychologia . 2008;46(13): 3021-3029.

25.

Eichenbaum H. Conscious awareness, memory and the hippocampus . Nat Neurosci. 1999;2(9):775-776.

26.

Stark CE , Okado Y. Making memories without trying: medial temporal lobe activity associated with incidental memory formation during recognition. J Neurosci . 2003;23(17):6748-6753.

27.

Rombouts ARB , Machielsen WCM , Witter MP , et al. Visual association encoding activated the medial temporal lobe: a functional magnetic resonance imaging study. Hippocampus. 1997 ;7(6):594-601.

28.

Ikeda E. , Shiozaki K. , Takahashi N. , et al. Total Mini-Mental State Examination score and regional cerebral blood flow using Z score imaging and automated ROI analysis software in subjects with memory impairment. Ann Nucl Med. 2008 ;22(6):539-542.

29.

Poduslo SE , Neal M. , Herring K. , Shelly J. The apolipoprotein CI A allele as a risk factor for Alzheimer’s disease. Neurochem Res. 1998;23(3):361-367.

30.

Drigalenko E. , Poduslo S. , Elston R. Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer’s disease. Neurology. 1998;51(1):131-135.

31.

Retz W. , Thome J. , Durany N. , et al. Potential genetic markers of sporadic Alzheimer’s dementia . Psychiatr Genet. 2001;11(3):115122.

32.

Gautier T. , Masson D. , Jong MC , et al. Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein(CETP) in CETP transgenic/ApoCI-knocked out mice. J Biol Chem. 2002;277(35): 31354-31363.

33.

Lahiri DK Apolipoprotein E as a target for developing new therapeutic for Alzheimer’s disease based on studies from protein, RNA and regulatory region of the gene . J Mol Neurosci. 2004;23(3):225-233.

34.

Sehayek E. , Eisenberg S. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J Biol Chem. 1991;266(27): 18259-18267.

35.

Petit-Turcotte C. , Stohl SM , Beert U. , et al. Apolipoprotein C-I expression in the brain in Alzheimer’s disease. Neurobiol Dis. 2001;8(6):953-956.